Skip to content

Clinical trials

Active, not recruiting Carcinoma, Renal Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Active, not recruiting Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20191
20202
20214
20224
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
AstraZeneca2
National Cancer Institute (NCI)2
23andMe, Inc.1
Eisai Inc.1
Exelixis1
Fluidx Medical Technology, Inc.1
Genentech, Inc.1
GlaxoSmithKline1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell18
Colorectal Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Melanoma4
Neoplasm Metastasis4
Squamous Cell Carcinoma of Head and Neck4
Neoplasms3
Stomach Neoplasms3
Breast Neoplasms2
Carcinoma2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.